Scantox Group, Headquarters
Scantox A/S, Denmark
Scantox has since 1977 been based in Lille Skensved, located just 30 minutes from Copenhagen. The location makes it easy and convenient to pay a visit to the site, and it is today headquarters for the Scantox Group.
Scantox is one of the largest employers in the region, and a sought after partner for pharma and biotech companies around the world for a unique expertise and long track record. Current premises cover an area exceeding 8,500 m2, where all phases of the scientific research process take place.
The company has over the years made continuous investment in advanced housing facilities according to EU Directive 2010/63/EU, as well as in state-of-the-art laboratories, and meet and exceed the industry’s highest quality standards.
Scantox is fully licensed by Danish Authorities, and all processes are carried out on the most reliable equipment available in the industry today.
In 2022 Scantox acquired the two Swedish CRO’s – Timeline Bioresearch in Lund and Adlego Biomedical, located in Solna near Stockholm. In 2023 an additional entity was added to the Group, with the acquisition of Q&Q Labs AB in Gothenburg. The three entites are now Scantox Sweden.
The Swedish expansions brought leading capabilities within in efficacy, explorative research services and bioanalytical services; expanding the Scantox portfolio of offerings.
In 2023 Scantox acquired Solural Pharma, located in Ballerup. The location in Ballerup has strong expertise in all aspects of formulation development, GMP manufacturing and packaging to support phase 1 & 2 clinical trials. We develops formulations, from concept idea to clinical proof of concept, and our formulation technology platform provides innovative oral and topical products having unique benefits regarding efficacy, safety and convenience thereby meeting the needs from patients, doctors and society alike for the treatment of important medical conditions.
2750 Ballerup, Denmark